Trial updateCataract & IOL

Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

Not yet recruiting. Phase 2 / Phase 3. Registered enrolment: 60000. Jason Ahee, M.D.

Vision assessment with a trial frame
Stock photo · Ksenia Chernaya / Pexels

Why it matters

Track this study through NCT03244072. No results are posted in this registry record.

The study at a glance

Registry status
Not yet recruiting
Phase
Phase 2 / Phase 3
Registered enrolment
60000
Results posted
No
Sponsor
Jason Ahee, M.D.

Keep in mind

Registry information describes the study; recruitment status alone does not establish efficacy or safety.

References (1)
  1. ClinicalTrials.gov · NCT03244072

Source date: 15 Sept 2026 · United States

Report a correction

Connected reading